We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.26%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$2.27B
AUM Growth
+$198M
(+9.6%)
Cap. Flow
+$119M
Cap. Flow
% of AUM
5.25%
Top 10 Holdings %
Top 10 Hldgs %
35.16%
Holding
449
New
157
Increased
70
Reduced
62
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$84.2M |
| 2 |
Charter Communications
CHTR
|
+$83.5M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$56.6M |
| 4 |
Bank of America
BAC
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$38.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$170M |
| 2 |
T-Mobile US
TMUS
|
+$71.2M |
| 3 |
Advance Auto Parts
AAP
|
+$34.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$27.2M |
| 5 |
VAL
Valspar
VAL
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 15.94% |
| 2 | Healthcare | 14.24% |
| 3 | Communication Services | 13.98% |
| 4 | Consumer Discretionary | 11.95% |
| 5 | Technology | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
HubSpot
HUBS
$10.5B
| $431K | 0.02% |
+6,531
| New | +$441K |
|
252
Nektar Therapeutics
NKTR
$2.39B
| $429K | 0.02% |
+1,430
| New | +$413K |
|
|
ALXN
253
DELISTED
Alexion Pharmaceuticals
ALXN
| $427K | 0.02% |
3,504
-15,632
| -82% | -$1.82M |
|
254
Flowserve
FLS
$9.25B
| $422K | 0.02% |
9,169
-25,786
| -74% | -$1.24M |
|
255
Oracle
ORCL
$331B
| $418K | 0.02% |
+8,353
| New | +$381K |
|
|
MIME
256
DELISTED
Mimecast Limited
MIME
| $413K | 0.02% |
+15,293
| New | +$384K |
|
|
DFS
257
DELISTED
Discover Financial Services
DFS
| $411K | 0.02% |
+6,629
| New | +$411K |
|
258
Edgewell Personal Care
EPC
$1.27B
| $405K | 0.02% |
+5,323
| New | +$392K |
|
259
Pentair
PNR
$10.2B
| $403K | 0.02% |
+8,955
| New | +$391K |
|
260
Marriott International
MAR
$98.7B
| $400K | 0.02% |
+4,000
| New | +$400K |
|
261
CME Group
CME
$92.2B
| $392K | 0.02% |
+3,133
| New | +$375K |
|
262
Zebra Technologies
ZBRA
$12.4B
| $389K | 0.02% |
+3,856
| New | +$382K |
|
|
AGR
263
DELISTED
Avangrid, Inc.
AGR
| $369K | 0.02% |
+8,377
| New | +$372K |
|
264
Lincoln National
LNC
$7.91B
| $355K | 0.02% |
+5,222
| New | +$345K |
|
265
Norfolk Southern
NSC
$78.8B
| $353K | 0.02% |
2,890
-10,187
| -78% | -$1.2M |
|
|
WBMD
266
DELISTED
WebMD Health Corp.
WBMD
| $345K | 0.02% |
+5,842
| New | +$326K |
|
267
D.R. Horton
DHI
$41B
| $340K | 0.02% |
+9,727
| New | +$325K |
|
268
FTI Consulting
FCN
$4.82B
| $340K | 0.02% |
9,704
-206
| -2% | -$7.52K |
|
|
BIVV
269
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $340K | 0.02% |
+5,664
| New | +$323K |
|
|
TWNK
270
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $337K | 0.01% |
+21,032
| New | +$340K |
|
|
GAP
271
The Gap Inc
GAP
$6.84B
| $321K | 0.01% |
14,595
-87,654
| -86% | -$2.09M |
|
|
LOGM
272
DELISTED
LogMein, Inc.
LOGM
| $320K | 0.01% |
+3,044
| New | +$333K |
|
273
Sonoco
SON
$5.76B
| $319K | 0.01% |
+6,256
| New | +$322K |
|
274
Carpenter Technology
CRS
$30B
| $314K | 0.01% |
+8,491
| New | +$315K |
|
275
Constellation Brands
STZ
$22.2B
| $312K | 0.01% |
1,608
-4,826
| -75% | -$859K |
|
Similar funds
Marshall Wace's Q2 2017 Portfolio in Review
As of Q2 2017, Marshall Wace held 449 positions worth $2.27B, up 9.6% from $2.07B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $119M of net new capital in Q2 2017, opening 157 new positions and adding to 70 existing holdings. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 742,458 shares worth $58.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 16% of assets, up from 11% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Zoetis, an estimated $170M trimmed.
- Marshall Wace's largest Q2 2017 buy was State Street Health Care Select Sector SPDR ETF: 742,458 shares worth $58.7M.
- Marshall Wace added most to Reynolds American Inc in Q2 2017, an estimated $84.2M increase.
- Marshall Wace's biggest Q2 2017 reduction was Zoetis, cutting an estimated $170M.
- Marshall Wace fully exited Advance Auto Parts in Q2 2017, selling an estimated $34.1M.
- Marshall Wace's ten largest holdings make up 35% of its $2.27B portfolio in Q2 2017.
- Marshall Wace opened 157 new positions and closed 148 in Q2 2017.
- Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $2.27B.
Based on Marshall Wace's 13F filing for Q2 2017, filed 4 Aug 2017.